Zinc supplementation could prevent type 2 diabetes in obese patients Medha Baranwal5 July 2023 11:30 AM ISTTaiwan: Zinc supplementation is beneficial for blood sugar control in patients with overweight/obesity, with an especially significant reduction in...
GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis Medha Baranwal5 July 2023 9:45 AM ISTTaiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like...
Health Bulletin 04/July/2023 Roshni Dhar4 July 2023 5:00 PM ISTHere are the top health stories for the day: Should the 2019 MBBS batch give the NExT exam? Doctors point out violations of the NMC actMBBS Students...
Dulaglutide may prevent diabetic kidney disease in patients with type 2 diabetes Medha Baranwal4 July 2023 11:15 AM ISTUSA: Dulaglutide (DU) may slow the development of diabetic kidney disease in patients with type 2 diabetes (T2D), as indicated by an estimated 25%...
Higher glycemia levels during childhood are tied to future microvascular complications Medha Baranwal4 July 2023 10:15 AM ISTUSA: A recent study has stressed the importance of early glycemic screening in high-risk children to prevent long-term diabetes complications.The...
Bariatric surgery superior to standard diabetes management for glycemic control, remission of type 2 diabetes: Study Dr. Kamal Kant Kohli3 July 2023 10:15 AM ISTUSA: A study of over 250 participants for up to 12 years revealed that metabolic or bariatric surgery results in less medication use, superior...
Type 2 diabetes: Combo of semaglutide and cagrilintide reduces blood sugar and leads to weight loss Medha Baranwal1 July 2023 11:00 AM ISTUSA: Co-administration of once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg (CagriSema) improves glycemic control and leads to...
Early introduction of SGLT2 Inhibitors attenuates association between dysglycaemia and CVD risk: Lancet Medha Baranwal29 Jun 2023 8:00 PM ISTItaly: Poor glycemic control in the first three years after diagnosis is associated with a subsequent increased risk of cardiovascular disease (CVD)...
AstraZeneca Xigduo XR approved in China for adults with type 2 diabetes Ruchika Sharma28 Jun 2023 4:30 PM ISTChina: AstraZeneca’s Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily fixed-dose combination, has been approved by...
Breastfeeding can help prevent type 2 diabetes in mothers, study claims Dr. Kamal Kant Kohli28 Jun 2023 9:30 AM ISTUSA: Breastfeeding can help protect mothers against type 2 diabetes in later years by increasing insulin sensitivity and improving the number of...
Once-weekly insulin icodec noninferior to once-daily insulin degludec for HbA1c reduction in type 2 diabetes: ONWARDS 3 trial Medha Baranwal27 Jun 2023 10:45 AM ISTDenmark: The ONWARDS 3 randomized clinical trial showed the efficacy of once-weekly insulin icodec treatment in patients with insulin-naive type 2...
Canagliflozin has no effect on SBP variability and associated CV and renal complications: JAHA Medha Baranwal27 Jun 2023 10:00 AM ISTAustralia: Analysis of participants' data from the CANVAS and CREDENCE Trials revealed that canagliflozin (an SGLT2 inhibitor) has little or no effect...
